(Q39165812)

9 September 2017

Insulin-like growth factor 1 receptor promotes the growth and chemoresistance of pancreatic cancer (English)

1 reference

9 September 2017

1 reference

Xiaodong Tian

1

1 reference

9 September 2017

Kun Hao

2

1 reference

9 September 2017

Changfu Qin

3

1 reference

9 September 2017

Kun Xie

4

1 reference

9 September 2017

Xuehai Xie

5

1 reference

9 September 2017

Yinmo Yang

6

1 reference

9 September 2017

16 April 2013

1 reference

Digestive Diseases and Sciences

9 September 2017

1 reference

9 September 2017

58

1 reference

9 September 2017

9

1 reference

9 September 2017

2705-2712

1 reference

https://scigraph.springernature.com/pub.10.1007/s10620-013-2673-2

9 September 2017

0 references

cites work

Novel medical therapies of recurrent and metastatic gastroenteropancreatic neuroendocrine tumors.

1 reference

https://api.crossref.org/works/10.1007%2FS10620-013-2673-2

Clinical significance of vascular endothelial growth factor and connexin43 for predicting pancreatic cancer clinicopathologic parameters.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-013-2673-2

Type I insulin-like growth factor receptor as a therapeutic target in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-013-2673-2

Disrupting insulin-like growth factor signaling as a potential cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-013-2673-2

miR-17-5p inhibitor enhances chemosensitivity to gemcitabine via upregulating Bim expression in pancreatic cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-013-2673-2

Biological rationale and current clinical experience with anti-insulin-like growth factor 1 receptor monoclonal antibodies in treating sarcoma: twenty years from the bench to the bedside

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-013-2673-2

AMG 479, a fully human anti-insulin-like growth factor receptor type I monoclonal antibody, inhibits the growth and survival of pancreatic carcinoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-013-2673-2

The efficacy of IGF-I receptor monoclonal antibody against human gastrointestinal carcinomas is independent of k-ras mutation status.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-013-2673-2

Detection and downregulation of type I IGF receptor expression by antibody-conjugated quantum dots in breast cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-013-2673-2

Down-regulation of IGF-1R expression inhibits growth and enhances chemosensitivity of endometrial carcinoma in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-013-2673-2

Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: a randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-013-2673-2

Resistance of pancreatic cancer to gemcitabine treatment is dependent on mitochondria-mediated apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-013-2673-2

NF-kappaB in pancreatic cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-013-2673-2

Inhibition of AKT2 enhances sensitivity to gemcitabine via regulating PUMA and NF-κB signaling pathway in human pancreatic ductal adenocarcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-013-2673-2

Wortmannin inhibits pkb/akt phosphorylation and promotes gemcitabine antitumor activity in orthotopic human pancreatic cancer xenografts in immunodeficient mice.

21 January 2018

1 reference

12 December 2020

Phosphatidylinositol 3-kinase as a mediator of TNF-induced NF-kappa B activation

1 reference

12 December 2020

Insulin-like growth factor I overexpression in human pancreatic cancer: evidence for autocrine and paracrine roles.

1 reference

12 December 2020

NFkappaB-dependent chemoresistance in solid tumors.

1 reference

12 December 2020

10.1007/S10620-013-2673-2

Identifiers

DOI

1 reference

release_xwclygc54ne5tceluxbi37uhia

9 September 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/xwclygc54ne5tceluxbi37uhia

24 November 2022

mapped directly with Wikidata item

1 reference